Ventrus Biosciences (VTUS) is a specialty pharmaceutical company focused on the development and commercialization of late-stage prescription drugs for gastrointestinal disorders, specifically hemorrhoids, anal fissures and fecal incontinence. This stock is trading up 1.5% at $10.13 in recent trading.
Today's Volume: 120,000Average Volume: 76,941 Volume % Change: 117% From a technical perspective, VTUS is starting to bounce today right off its 50-day moving average of $10.10 with above average volume. This move is quickly pushing the stock within range of triggering a major near-term breakout trade. That trade will hit once VTUS takes out some near-term overhead resistance at $11.15 to $12 with high volume. Traders should look for long-biased trades if VTUS can sustain a move and close over $11.15 to $12 with volume that's near or well above 76,941 shares. If we get that action today or soon, look for VTUS to make a run at $15 or higher in the near future. To see more stocks rising on unusual volume, check out the Stocks Rising On Unusual Volume portfolio on Stockpickr. -- Written by Roberto Pedone in Winderemere, Fla.
Twitter and become a fan on Facebook.